WASHINGTON, D.C. – U.S. Sen. Sherrod Brown today applauded a major announcement by the U.S. Department of Health and Human Services (HHS) that it will launch a targeted initiative aimed at reducing prescription opioid and heroin related overdose, death, and dependence. In response to today’s announcement, Brown issued the following statement:
“Too many Ohioans have been affected by drug abuse, which has become one of our country’s greatest public health challenges,” Brown said. “Today’s announcement will invest in lifesaving medicine that can prevent deaths from prescription drug abuse and ensure that more health professionals can help prevent and treat prescription drug abuse.”
Specifically, today’s announcement by HHS will provide additional federal support in the development and distribution of naloxone, a medicine which helps reverse overdoses. It would also invest in additional prevention efforts and expand treatment options.
Brown wrote to the head of HHS in December, urging her to prioritize overdose prevention and invest in naloxone as a way to prevent deaths from prescription drug overdose. A copy of that letter can be found here.